Cargando…

Microfluidics‐Enabled Nanovesicle Delivers CD47/PD‐L1 Antibodies to Enhance Antitumor Immunity and Reduce Immunotoxicity in Lung Adenocarcinoma

The CD47/PD‐L1 antibodies combination exhibits durable antitumor immunity but also elicits excessive immune‐related adverse events (IRAEs) caused by the on‐target off‐tumor immunotoxicity, hindering their clinical benefits greatly. Here, a microfluidics‐enabled nanovesicle using ultra‐pH‐sensitive p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Su, Zhenwei, Dong, Shaowei, Chen, Yao, Huang, Tuxiong, Qin, Bo, Yang, Qinhe, Jiang, Xingyu, Zou, Chang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10369263/ https://www.ncbi.nlm.nih.gov/pubmed/37132609 http://dx.doi.org/10.1002/advs.202206213

Ejemplares similares

Microfluidic Synthesis of Rigid Nanovesicles for Hydrophilic Reagents Delivery**
por: Zhang, Lu, et al.
Publicado: (2015)

Protocol to prepare functional cellular nanovesicles with PD1 and TRAIL to boost antitumor response
por: Yu, Peiwen, et al.
Publicado: (2021)

Risk assessment on-a-chip: a cell-based microfluidic device for immunotoxicity screening
por: Oddo, Arianna, et al.
Publicado: (2020)

Activated platelet membrane nanovesicles recruit neutrophils to exert the antitumor efficiency
por: Shang, Yinghui, et al.
Publicado: (2022)

In vivo assessment of immunotoxicity
por: Munson, Albert E., et al.
Publicado: (1982)

A comparison of immunotoxic effects of nanomedicinal products with regulatory immunotoxicity testing requirements
por: Giannakou, Christina, et al.
Publicado: (2016)

Fraction From Lycium barbarum Polysaccharides Reduces Immunotoxicity and Enhances Antitumor Activity of Doxorubicin in Mice
por: Deng, Xiangliang, et al.
Publicado: (2018)

PD-1 Cellular Nanovesicles Carrying Gemcitabine to Inhibit the Proliferation of Triple Negative Breast Cancer Cell
por: Zha, Hualian, et al.
Publicado: (2022)

STING agonist-loaded, CD47/PD-L1-targeting nanoparticles potentiate antitumor immunity and radiotherapy for glioblastoma
por: Zhang, Peng, et al.
Publicado: (2023)

An antitumor peptide RS17‐targeted CD47, design, synthesis, and antitumor activity
por: Wang, Xinmin, et al.
Publicado: (2021)

BDE-47 Induces Immunotoxicity in RAW264.7 Macrophages through the Reactive Oxygen Species-Mediated Mitochondrial Apoptotic Pathway
por: Gao, Qian, et al.
Publicado: (2023)

New approaches to immunotoxicity testing.
por: Archer, D L
Publicado: (1982)

Exploring the Immunotoxicity of Carbon Nanotubes
por: Yu, Yanmei, et al.
Publicado: (2008)

Arsenic immunotoxicity: a review
por: Dangleben, Nygerma L, et al.
Publicado: (2013)

Mechanisms of Immunotoxicity: Stressors and Evaluators
por: Bou Zerdan, Maroun, et al.
Publicado: (2021)

Dual checkpoint blockade of CD47 and PD-L1 using an affinity-tuned bispecific antibody maximizes antitumor immunity
por: Chen, Shih-Hsun, et al.
Publicado: (2021)

Investigating Molecular Mechanisms of Immunotoxicity and the Utility of ToxCast for Immunotoxicity Screening of Chemicals Added to Food
por: Naidenko, Olga V., et al.
Publicado: (2021)

Deformable Nanovesicles Synthesized through an Adaptable Microfluidic Platform for Enhanced Localized Transdermal Drug Delivery
por: Subbiah, Naren, et al.
Publicado: (2017)

Functional nanovesicles displaying anti-PD-L1 antibodies for programmed photoimmunotherapy
por: Chen, Hu, et al.
Publicado: (2022)

Dual pH-sensitive nanodrug blocks PD-1 immune checkpoint and uses T cells to deliver NF-κB inhibitor for antitumor immunotherapy
por: Xiao, Zecong, et al.
Publicado: (2020)

Approaches to the evaluation of chemical-induced immunotoxicity.
por: Krzystyniak, K, et al.
Publicado: (1995)

Methods and approaches for assessing immunotoxicity: an overview.
por: Dean, J H, et al.
Publicado: (1982)

Selected new developments in asbestos immunotoxicity.
por: Rosenthal, G J, et al.
Publicado: (1998)

Screening tests for autoimmune-related immunotoxicity.
por: Pieters, R, et al.
Publicado: (1999)

CHEMICAL TESTING: Developmental Immunotoxicity in Review
por: Spivey, Angela
Publicado: (2009)

Zearalenone, an Estrogenic Mycotoxin, Is an Immunotoxic Compound
por: Hueza, Isis M., et al.
Publicado: (2014)

Microcystin-LR Induced Immunotoxicity in Mammals
por: Lone, Yaqoob, et al.
Publicado: (2016)

Neurological Immunotoxicity from Cancer Treatment
por: Wesley, Sarah F., et al.
Publicado: (2021)

The mechanisms of aluminum-induced immunotoxicity in chicks
por: Cao, Changyu, et al.
Publicado: (2022)

Acerola exosome-like nanovesicles to systemically deliver nucleic acid medicine via oral administration
por: Umezu, Tomohiro, et al.
Publicado: (2021)

Erythrocyte nanovesicles: Biogenesis, biological roles and therapeutic approach: Erythrocyte nanovesicles
por: Harisa, Gamaleldin I., et al.
Publicado: (2017)

NOTCH4(ΔL12_16) sensitizes lung adenocarcinomas to EGFR-TKIs through transcriptional down-regulation of HES1
por: Zhang, Bin, et al.
Publicado: (2023)

A Logic-Gated Modular Nanovesicle Enables Programmable Drug Release for On-Demand Chemotherapy
por: Tang, Longguang, et al.
Publicado: (2019)

Consensus workshop on methods to evaluate developmental immunotoxicity.
por: Luster, Michael I, et al.
Publicado: (2003)

Immunotoxicity of PCBs (Aroclors) in relation to Great Lakes.
por: Tryphonas, H
Publicado: (1995)

Immunotoxicity of heavy metals in relation to Great Lakes.
por: Bernier, J, et al.
Publicado: (1995)

Developmental Immunotoxicity Testing and Protection of Children's Health
por: Dietert, Rodney R
Publicado: (2006)

Biomarkers of Immunotoxicity for Environmental and Public Health Research
por: Duramad, Paurene, et al.
Publicado: (2011)

Immunotoxicity Risk Assessment for Chemicals and Regulatory Science
por: ARAKAWA, Yasuaki
Publicado: (2014)

Histological and histometrical evidences for phenol immunotoxicity in mice
por: Louei Monfared, Ali, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_rhsimji2s1uvk4iqfbms9hnhel